STOCK TITAN

Cra Intl Inc Form 4 Filings

CRAI NASDAQ

Every Form 4 that Cra Intl Inc (CRAI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CRAI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CRAI filings page.

Rhea-AI Summary

CRA International, Inc. reported that its President and CEO, who also serves as a director, received several restricted stock unit (RSU) awards on 12/12/2025. Each RSU represents a contingent right to receive one share of common stock, payable in cash, shares, or a combination, and accrues additional RSUs as dividend equivalent rights when dividends are paid.

The new RSU grants include Dividend Units such as 88.4555, 127.3641, 99.3368, 174.3620, 78.6585 and 35.3720 units in different awards, with vesting dates on March 10, 2026 and in annual installments beginning April 11, 2026, April 29, 2026 and May 20, 2026. After these transactions, the reporting person beneficially owned 116,545 shares of common stock directly, as well as nonqualified stock options covering 16,304 shares at an exercise price of $44.87 and 15,173 shares at $47.45.

Rhea-AI Summary

CRA International, Inc. reported an executive equity award involving restricted stock units (RSUs) linked to its common stock. On December 12, 2025, the reporting officer acquired 2.0954 RSUs, and following this transaction beneficial ownership increased to 737.9104 RSUs, held directly.

Each RSU represents a contingent right to receive one share of CRA International common stock and may be settled in cash, shares, or a combination. Shares, when issued, are delivered as soon as possible after vesting and no later than two and one-half months after the end of the year in which vesting occurs, subject to tax withholding. Dividend equivalent rights accrue on unvested RSUs as additional RSUs, called Dividend Units, which vest on the same schedule. The RSUs, which include an aggregate of 3.9104 Dividend Units, vest in four equal annual installments beginning on August 4, 2026.

Rhea-AI Summary

CRA International's EVP and chief corporate development officer reported updated equity holdings as of 12/12/2025. The filing shows beneficial ownership of 44,858 shares of common stock held directly.

The executive also reports several blocks of restricted stock units, with post-transaction balances including 459.7215 and 662.8693 units, each representing a contingent right to receive one share of common stock and accruing dividend equivalent units that vest on the same schedule. These RSUs vest on dates ranging from March 10, 2026 to May 20, 2026, some in equal annual installments. In addition, the report lists nonqualified stock options to purchase 4,076 shares at $44.87 expiring on 12/18/2027 and 4,425 shares at $47.45 expiring on 12/06/2028, each originally granted to vest in four equal annual installments beginning one year after grant.

Rhea-AI Summary

A director of CRA International, Inc. reported a small sale of company stock. On 12/11/2025, the director sold 110 shares of common stock at a price of $198.12 per share, coded as a sale transaction ("S"). After this trade, the director beneficially owns 2,941 shares of CRA International common stock in direct ownership.

The company notes that this transaction was carried out under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025, which is designed to allow scheduled trading of shares under specified conditions.

Rhea-AI Summary

CRA International, Inc. (CRAI) executive vice president and general counsel reported multiple open-market sales of company common stock. On 11/20/2025, the reporting person sold 1,317 shares at a weighted average price of $174.1586, 343 shares at $174.8737, 60 shares at $175.4279, and 30 shares at $176.3925, all coded as sales.

After these transactions, the reporting person beneficially owned 15,573 shares of CRA International common stock held directly. The filing notes that all transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on August 8, 2024, and that the prices shown are weighted averages for trades executed within specified intraday price ranges.

Rhea-AI Summary

Jonathan D. Yellin, EVP & General Counsel of CRA International, Inc. (CRAI), reported changes in beneficial ownership on Form 4. The filing shows a sale of 17,323 shares of common stock on 09/12/2025. It also reports multiple restricted stock unit (RSU) acquisitions granted on 09/12/2025 that convert to common shares upon vesting, with individual RSU tranche sizes equivalent to 0.9813, 1.4114, 1.5524, 2.7262, 2.1544 and 2.2041 underlying shares (totaling the reported RSU share equivalents shown). The filer also holds outstanding nonqualified stock options for 2,377 and 2,845 shares with exercise prices of $44.87 and $47.45, expiring in 2027 and 2028 respectively. The RSUs include dividend equivalent units and have specified vesting schedules between March 10, 2026 and May 20, 2026.

Rhea-AI Summary

Eric Nierenberg, EVP, CFO and Treasurer of CRA International, Inc. (CRAI), reported on Form 4 a grant of 1.815 restricted stock units (RSUs) on 09/12/2025. The filing shows the RSUs were recorded as acquired at a $0 price and that following the grant the reporting person beneficially owns 735.815 shares of common stock. The RSUs include 1.815 Dividend Units that accrue dividend equivalents and vest on the same schedule. The RSUs vest in four equal annual installments beginning on August 4, 2026. The Form 4 was signed by an attorney-in-fact, Delia J. Makhlouta, on 09/16/2025.

Rhea-AI Summary

Paul A. Maleh, President and CEO and a director of CRA International, Inc. (CRAI), reported a transaction dated 09/12/2025. The Form 4 shows a disposition of 124,045 shares of CRAI common stock. On the same date the reporting person received multiple awards of restricted stock units (RSUs) that convert to shares on specified vesting schedules, with individual underlying share amounts shown (aggregate per award shown as fractional and whole-share amounts). The filing also lists existing nonqualified stock options covering 16,304 and 15,173 shares with exercise prices of $44.87 and $47.45, respectively, and standard multi-year vesting. The Form 4 was filed by power of attorney on 09/16/2025.

Rhea-AI Summary

Brian Langan, an officer of CRA International, Inc. (CRAI), reported on Form 4 that he acquired 1.815 restricted stock units (RSUs) on 09/12/2025. The filing shows 735.815 shares beneficially owned following the reported transaction. The RSUs include 1.815 Dividend Units and vest in four equal annual installments beginning August 4, 2026. Vested RSUs may be settled in cash, shares or a combination, and shares delivered for vested RSUs will be issued as soon as practicable but no later than two and one-half months after year-end, subject to tax withholding. The Form 4 was signed by power of attorney on 09/16/2025 and lists Mr. Langan’s title as Executive Vice President and Chief Strategy and Business Transformation Officer.

Rhea-AI Summary

Chad M. Holmes, EVP and Chief Corporate Development Officer of CRA International, Inc. (CRAI), filed a Form 4 reporting transactions dated 09/12/2025. The filing shows a disposition of 44,858 shares of CRAI common stock and multiple awards of restricted stock units (RSUs) granted on the same date. The RSUs are payable in cash, shares, or a combination and include dividend-equivalent units; specific RSU amounts reported are 458.4161, 660.9871, 726.2141, 1,275.2496, 822.6525, and 841.3452 units with varied vesting schedules between March and May 2026 and subsequent annual installments. The filing also reiterates existing nonqualified stock options exercisable through 2027 and 2028.